Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Niusule Bio-Pharmace (NIUS)

Niusule Bio-Pharmace (NIUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Niusule Bio-Pharmace

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Niusule Bio-Pharmaceutical Corp. formerly Niusule Biotech Corp. is a Nevada corporation formed on April 8, 2008. It is a bio-pharmaceutical company dedicated to enhance both human (children) and animal health. The Company caters to China's rapidly growing demand for safe and products. For the human line, Niusule currently has a retail distribution network throughout China comprised of 124 outlets at high-end supermarkets and shopping malls in Zhejiang province, Shanghai and Beijing. The Company is aggressively seeking to expand into other regions. Regarding animal health, through the Company's affiliate, Niusule Behigh (Tianjin ) Pharmaceutical Group Co., Ltd, the Company has acquired the veterinary drugs and feed additives manufacturing license issued by China's Ministry of Agriculture and has 183 products.Niusule Behigh (Tianjin ) Pharmaceutical Group Co., Ltd has 10 Good Manufacturing Practice (GMP) production lines certified by the China's Ministry of Agriculture for small volume injection, tablets, granules, oral solutions, powder, pelvis, disinfectant, and purring.

Key Statistics

Overview:

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 100.00%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Dividend Payout Ratio 0.00%

NIUS Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 0.12
Price/Book 0.04
Book Value/Share N/A
Interest Coverage N/A
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar